Patient-specific radiation dose and cancer risk estimation in CT: part I. development and validation of a Monte Carlo program.
about
Patient-specific radiation dose and cancer risk estimation in CT: part II. Application to patients.Patient-based estimation of organ dose for a population of 58 adult patients across 13 protocol categoriesToward real-time Monte Carlo simulation using a commercial cloud computing infrastructure.The impact on CT dose of the variability in tube current modulation technology: a theoretical investigation.In vitro dose measurements in a human cadaver with abdomen/pelvis CT scansPediatric chest and abdominopelvic CT: organ dose estimation based on 42 patient models.Organ localization: toward prospective patient-specific organ dosimetry in computed tomography.Population of anatomically variable 4D XCAT adult phantoms for imaging research and optimizationComparison of conventional and simulated reduced-tube current MDCT for evaluation of suspected appendicitis in the pediatric population.Patient-specific radiation dose and cancer risk for pediatric chest CT.Development and validation of a GEANT4 radiation transport code for CT dosimetryThe development of a population of 4D pediatric XCAT phantoms for imaging research and optimizationOrgan doses, effective doses, and risk indices in adult CT: comparison of four types of reference phantoms across different examination protocolsDevelopment of a database of organ doses for paediatric and young adult CT scans in the United KingdomPatient-specific dose calculations for pediatric CT of the chest, abdomen and pelvisEffects of protocol and obesity on dose conversion factors in adult body CT.Monte Carlo simulations of adult and pediatric computed tomography exams: validation studies of organ doses with physical phantomsA Monte Carlo study on quantifying the amount of dose reduction by shielding the superficial organs of an Iranian 11-year-old boy.Comparison of patient specific dose metrics between chest radiography, tomosynthesis, and CT for adult patients of wide ranging body habitus.Comparison of organ dosimetry methods and effective dose calculation methods for paediatric CT.Accuracy of Monte Carlo simulations compared to in-vivo MDCT dosimetry.Application of the 4D XCAT Phantoms in Biomedical Imaging and Beyond.Extending the concept of weighted CT dose index to elliptical phantoms of various aspect ratios.Realistic phantoms to characterize dosimetry in pediatric CT.The role of Size-Specific Dose Estimate (SSDE) in patient-specific organ dose and cancer risk estimation in paediatric chest and abdominopelvic CT examinations.Adult abdomen-pelvis CT: Does equilibrium dose-pitch product better account for the kVp dependence of organ dose than conventional CTDI?Evaluation of organ doses in adult and paediatric CT examinations based on Monte Carlo simulations and in-phantom dosimetry.An angle-dependent estimation of CT x-ray spectrum from rotational transmission measurements.Automated, patient-specific estimation of regional imparted energy and dose from tube current modulated computed tomography exams across 13 protocols.Pediatric radiation dosimetry for positron-emitting radionuclides using anthropomorphic phantoms.Validation of a Monte Carlo model used for simulating tube current modulation in computed tomography over a wide range of phantom conditions/challenges.Size-based quality-informed framework for quantitative optimization of pediatric CT.Assessment of CT dose to the fetus and pregnant female patient using patient-specific computational models.Radiation risk index for pediatric CT: a patient-derived metric.Breast dose reduction with organ-based, wide-angle tube current modulated CT.CT breast dose reduction with the use of breast positioning and organ-based tube current modulation.Voxel dosimetry: Comparison of MCNPX and DOSXYZnrc Monte Carlo codes in patient specific phantom calculations.Deterministic absorbed dose estimation in computed tomography using a discrete ordinates method.Effect of ROI filtering in 3D cone-beam rotational angiography on organ dose and effective dose in cerebral investigations.GMctdospp: Description and validation of a CT dose calculation system.
P2860
Q33832721-9D6D4E38-D57E-472E-8B2D-A1A3686954F0Q33929874-782F3AB2-36CA-4A86-9BD9-0E9F961BA6A4Q33992866-C5DED309-5022-4B26-A9E8-27B2CCBE3700Q34093595-ABC69653-0C65-44D3-B423-6D9968D8C842Q34110955-932510C8-8B61-4AE5-A656-5468B8D0683DQ34495448-DCB083A5-32A0-47CC-9030-C200741AE1E9Q34558133-3370E325-5B07-44C3-800D-B18F4DDE2049Q34654893-01510E50-2F08-4C1B-97F0-C05BAD69C7DDQ34974163-612E09A1-FCDD-4BEC-87D3-7351D89F2188Q34995945-7501DB4A-72BD-46B6-B3CF-0934BF49CC76Q35117061-6C5CF128-F81B-414A-8609-70428A9358FFQ35732948-A8146A88-42EB-45FA-A432-817071EF6DC2Q36019652-21DE9652-DA31-439C-A280-B07F1B08068BQ36104819-B316A719-7ACC-4743-A59C-50022B8BB39DQ36218061-67E09754-87CA-4FEF-8B45-8FEC03C838DDQ36350577-01FAEAAB-89EA-4BDB-B2D7-A8DBF8612F91Q36510562-69715B86-DC78-4865-AEFD-03F11F192C37Q37581569-7EA558AF-6BCF-4E99-8402-70FAD87D64E4Q37701613-0D6C2C13-4468-4D8A-923C-C24FABB4A844Q38001621-B0359A70-5591-48BD-A715-0DD269E67D48Q38344482-725DACF9-BCAA-448E-8E87-E350225A6323Q38623974-B14D8488-A3AA-474A-980C-9416197D8BB8Q38684989-D133BC3C-3C19-4B19-972E-8EED77D6147AQ38913960-3AB79EEF-04BC-455B-9DE3-34A1C46AB2A7Q40209382-D4F5DBEE-2C66-4AF7-968C-12900F1F535FQ40370980-DE2B2B41-5385-4ED1-A8F0-3D9E638F50CEQ41108402-29FC2E1B-8B47-41E3-9B00-D5DC5468D919Q43407101-39287046-AB8C-40BF-8710-4BE85901DB34Q44627496-B542D882-7288-4C7F-A4A5-67F3CC9FAEC1Q46030477-FDEF8532-3E89-4820-96C7-B63A9BA165B1Q46076214-D88B8AB3-BA6E-4656-9DCA-8E6EF4AF5F80Q47192179-D734361E-02F1-41E2-AC42-D0597DA311FFQ47274512-163632EF-E8D0-45D3-9327-A204004E1DDFQ47736471-21E2E639-24C6-4337-95B6-A5AC55E05AC5Q47799162-A9074351-66E0-4ABD-8D8C-D3827F92DCB6Q47904938-E550E98B-C312-49D7-A645-CF287A1E6898Q50605978-3E8724E7-D00E-429C-8EA7-5306E4C9BAC1Q50889489-2A43DF4A-F379-4941-BC56-CD66FBE3C46DQ51013343-CC346C23-D3BF-4942-AA59-7FDA25961889Q52999438-058564B9-FCFD-4EE6-AC22-562947C318C5
P2860
Patient-specific radiation dose and cancer risk estimation in CT: part I. development and validation of a Monte Carlo program.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Patient-specific radiation dos ...... tion of a Monte Carlo program.
@ast
Patient-specific radiation dos ...... tion of a Monte Carlo program.
@en
Patient-specific radiation dos ...... tion of a Monte Carlo program.
@nl
type
label
Patient-specific radiation dos ...... tion of a Monte Carlo program.
@ast
Patient-specific radiation dos ...... tion of a Monte Carlo program.
@en
Patient-specific radiation dos ...... tion of a Monte Carlo program.
@nl
prefLabel
Patient-specific radiation dos ...... tion of a Monte Carlo program.
@ast
Patient-specific radiation dos ...... tion of a Monte Carlo program.
@en
Patient-specific radiation dos ...... tion of a Monte Carlo program.
@nl
P2093
P2860
P356
P1433
P1476
Patient-specific radiation dos ...... ation of a Monte Carlo program
@en
P2093
Ehsan Samei
Gregory M Sturgeon
Greta Toncheva
James G Colsher
Terry T Yoshizumi
W Paul Segars
P2860
P304
P356
10.1118/1.3515839
P407
P577
2011-01-01T00:00:00Z